[HTML][HTML] Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
B Godman, RE Malmström, E Diogene… - Frontiers in …, 2014 - frontiersin.org
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …
[PDF][PDF] Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
MJC Nuijten, A Accessus - researchgate.net
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …
Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
B Godman, RE Malmström, E Diogene… - Frontiers in …, 2014 - purerims.smu.ac.za
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …
[PDF][PDF] Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
MJC Nuijten, A Accessus - scienceopen.com
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …
Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
B Godman, RE Malmstrom, E Diogene… - Frontiers in …, 2014 - diva-portal.org
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …
Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
B Godman, RE Malmström, E Diogène Fadini… - Frontiers in …, 2014 - ddd.uab.cat
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …
[PDF][PDF] Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
MJC Nuijten, A Accessus - researchsystem.canberra.edu.au
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …
Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
B Godman, RE Malmström, E Diogene… - Frontiers in …, 2014 - portalrecerca.uab.cat
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …
[PDF][PDF] Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
MJC Nuijten, A Accessus - core.ac.uk
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …
[HTML][HTML] Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
B Godman, RE Malmström, E Diogene… - Frontiers in …, 2014 - ncbi.nlm.nih.gov
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are effectiveness, safety and/or budget …
premium priced drugs especially where there are effectiveness, safety and/or budget …